{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:52:37Z","timestamp":1792857157973,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.taap.2025.117247","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T16:11:41Z","timestamp":1738080701000},"page":"117247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Effects of melatonin on the pharmacokinetics and amino acid metabolism profile of vigabatrin in rats"],"prefix":"10.1016","volume":"496","author":[{"given":"Qiang","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song-Lin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Lin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Die","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Fang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2025.117247_bb0005","series-title":"Hypertyrosinemia. StatPearls. Treasure Island (FL) Ineligible Companies. Disclosure: Sandeep Puranik Declares no Relevant Financial Relationships with Ineligible Companies.: StatPearls Publishing Copyright \u00a9 2023","author":"Adnan","year":"2023"},{"key":"10.1016\/j.taap.2025.117247_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118826","article-title":"Revisiting the role of neurotransmitters in epilepsy: an updated review","volume":"265","author":"Akyuz","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2025.117247_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512405","article-title":"Pentylenetetrazole-induced seizures are increased after kindling, exhibiting vitamin-responsive correlations to the post-seizures behavior, amino acids metabolism and key metabolic regulators in the rat brain","volume":"24","author":"Aleshin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2025.117247_bb0020","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1017\/cjn.2021.156","article-title":"Treatment with high-dose prednisolone in Vigabatrin-refractory infantile spasms","volume":"49","author":"Al-Shehhi","year":"2022","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.taap.2025.117247_bb0025","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1600-079X.2010.00762.x","article-title":"Melatonin: a novel neuroprotectant for the treatment of glaucoma","volume":"48","author":"Belforte","year":"2010","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.taap.2025.117247_bb0030","article-title":"Mechanism of action of vigabatrin: correcting misperceptions","volume":"5-15","author":"Ben-Menachem","year":"2011","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.taap.2025.117247_bb0035","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/epi.12490","article-title":"Frontal lobe seizures: from clinical semiology to localization","volume":"55","author":"Bonini","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.taap.2025.117247_bb0040","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fncel.2013.00157","article-title":"The role of dopamine signaling in epileptogenesis","volume":"7","author":"Bozzi","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.taap.2025.117247_bb0045","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1210\/endo.135.1.8013371","article-title":"Characterization of melatonin receptors and signal transduction system in rat arteries forming the circle of Willis","volume":"135","author":"Capsoni","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.taap.2025.117247_bb0050","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/brain\/awy320","article-title":"The role of astrocytes in seizure generation: insights from a novel in vitro seizure model based on mitochondrial dysfunction","volume":"142","author":"Chan","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.taap.2025.117247_bb0055","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S1474-4422(23)00363-0","article-title":"Sleep, melatonin, and cardiovascular disease","volume":"22","author":"Covassin","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.taap.2025.117247_bb0060","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12985","article-title":"Optimizing the time and dose of melatonin as a sleep-promoting drug: a systematic review of randomized controlled trials and dose-response Meta-analysis","volume":"76","author":"Cruz-Sanabria","year":"2024","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.taap.2025.117247_bb0065","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1081\/RRS-100107144","article-title":"Expression of the MT1 melatonin receptor subtype in human coronary arteries","volume":"21","author":"Ekmekcioglu","year":"2001","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"10.1016\/j.taap.2025.117247_bb0070","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1034\/j.1600-079X.2003.00051.x","article-title":"The melatonin receptor subtype MT2 is present in the human cardiovascular system","volume":"35","author":"Ekmekcioglu","year":"2003","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.taap.2025.117247_bb0075","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.yebeh.2008.01.003","article-title":"Modern management of epilepsy: a practical approach","volume":"12","author":"Elger","year":"2008","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.taap.2025.117247_bb0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0014-2999(02)01407-3","article-title":"Constitutively active melatonin MT(1) receptors in male rat caudal arteries","volume":"439","author":"Er\u015fahin","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2025.117247_bb0085","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12967-019-1835-1","article-title":"Pediatric sleep disturbances and treatment with melatonin","volume":"17","author":"Esposito","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.taap.2025.117247_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179225","article-title":"Low doses of ketamine and melatonin in combination produce additive antidepressant-like effects in mice","volume":"22","author":"Estrada-Reyes","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2025.117247_bb0095","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/WNO.0000000000000609","article-title":"Vigabatrin: lessons learned from the United States experience","volume":"38","author":"Foroozan","year":"2018","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.taap.2025.117247_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115846","article-title":"Melatonin protects HT-22 cells against palmitic acid-induced glucolipid metabolic dysfunction and cell injuries: involved in the regulation of synaptic plasticity and circadian rhythms","volume":"217","author":"Gao","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2025.117247_bb0105","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10545-009-0922-5","article-title":"Mental retardation and inborn errors of metabolism","volume":"32","author":"Garc\u00eda-Cazorla","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.taap.2025.117247_bb0110","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.neuroscience.2012.07.044","article-title":"Muscarinic acetylcholine receptor-mediated effects in slices from human epileptogenic cortex","volume":"223","author":"Gigout","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.taap.2025.117247_bb0115","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00210-014-1080-3","article-title":"Different pharmacology of N-desmethylclozapine at human and rat M2 and M 4 mAChRs in neocortex","volume":"388","author":"Gigout","year":"2015","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.taap.2025.117247_bb0120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.seizure.2016.11.022","article-title":"Drug development for refractory epilepsy: the past 25 years and beyond","volume":"44","author":"Golyala","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.taap.2025.117247_bb0125","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s40263-019-00650-2","article-title":"Branched-chain amino acids and seizures: a systematic review of the literature","volume":"33","author":"Gruenbaum","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.taap.2025.117247_bb0130","first-page":"75","article-title":"Epilepsy and phenylketonuria: a case description and EEG-fMRI findings","volume":"29","author":"Guida","year":"2014","journal-title":"Funct. Neurol."},{"key":"10.1016\/j.taap.2025.117247_bb0135","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/jnc.12787","article-title":"Dynamics of hippocampal acetylcholine release during lithium-pilocarpine-induced status epilepticus in rats","volume":"131","author":"Hillert","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.taap.2025.117247_bb0140","first-page":"21","article-title":"P38 regulates Kainic acid-induced seizure and neuronal firing via Kv4.2 phosphorylation","author":"Hu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2025.117247_bb0145","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.neurol.2015.01.563","article-title":"Hippocampus and epilepsy: findings from human tissues","volume":"171","author":"Huberfeld","year":"2015","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.taap.2025.117247_bb0150","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10928-017-9511-7","article-title":"Comparison of non-compartmental and mixed effect modelling methods for establishing bioequivalence for the case of two compartment kinetics and censored concentrations","volume":"44","author":"Hughes","year":"2017","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.taap.2025.117247_bb0155","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fphar.2017.00057","article-title":"Nicotine elicits convulsive seizures by activating Amygdalar neurons","volume":"8","author":"Iha","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2025.117247_bb0160","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.2174\/1381612825666190829151314","article-title":"Melatonin as a modulator of degenerative and regenerative signaling pathways in injured retinal ganglion cells","volume":"25","author":"Juybari","year":"2019","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.taap.2025.117247_bb0165","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.etp.2017.05.002","article-title":"Protective effects of melatonin on long-term administration of fluoxetine in rats","volume":"69","author":"Khaksar","year":"2017","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.taap.2025.117247_bb0170","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1515\/revneuro-2019-0088","article-title":"The role of melatonin and its analogues in epilepsy","volume":"32","author":"Khan","year":"2020","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.taap.2025.117247_bb0175","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1684\/j.1950-6945.2002.tb00479.x","article-title":"Seizure-induced hippocampal damage in the mature and immature brain","volume":"4","author":"Lado","year":"2002","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.taap.2025.117247_bb0180","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/cbf.3651","article-title":"Abnormal neuronal damage and inflammation in the hippocampus of kainic acid-induced epilepsy mice","volume":"39","author":"Li","year":"2021","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.taap.2025.117247_bb0185","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1474-4422(05)70199-X","article-title":"The United Kingdom infantile spasms study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial","volume":"4","author":"Lux","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.taap.2025.117247_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101973","article-title":"Melatonin improves brain function in a model of chronic gulf war illness with modulation of oxidative stress, NLRP3 inflammasomes, and BDNF-ERK-CREB pathway in the hippocampus","volume":"43","author":"Madhu","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.taap.2025.117247_bb0195","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1001\/jama.2022.10597","article-title":"Review of Antiseizure medications for adults with epilepsy","volume":"328","author":"Maggiani","year":"2022","journal-title":"Jama"},{"key":"10.1016\/j.taap.2025.117247_bb0200","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1478-811X-11-34","article-title":"Complexity of dopamine metabolism","volume":"11","author":"Meiser","year":"2013","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.taap.2025.117247_bb0205","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2174\/1568026615666141209160556","article-title":"Melatonin redox activity. Its potential clinical applications in neurodegenerative disorders","volume":"15","author":"Miller","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.taap.2025.117247_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2022.107384","article-title":"Hippocampal ischaemia from accidental 5-Hydroxytryptophan (5-HTP) overdose case report","volume":"220","author":"Nash","year":"2022","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.taap.2025.117247_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2022.110695","article-title":"Melatonin for sleep disorders in people with autism: systematic review and meta-analysis","volume":"123","author":"Nogueira","year":"2023","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.taap.2025.117247_bb0220","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1474-4422(16)30294-0","article-title":"Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial","volume":"16","author":"O\u2019Callaghan","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.taap.2025.117247_bb0225","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3109\/07853890903485748","article-title":"Beneficial effects of melatonin in cardiovascular disease","volume":"42","author":"Reiter","year":"2010","journal-title":"Ann. Med."},{"key":"10.1016\/j.taap.2025.117247_bb0230","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2165\/00003088-199223040-00003","article-title":"Vigabatrin. Clinical pharmacokinetics","volume":"23","author":"Rey","year":"1992","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.taap.2025.117247_bb0235","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41582-022-00651-8","article-title":"The metabolic basis of epilepsy","volume":"18","author":"Rho","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.taap.2025.117247_bb0240","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/jpi.12008","article-title":"Therapeutic efficacy of melatonin in reducing retinal damage in an experimental model of early type 2 diabetes in rats","volume":"54","author":"Salido","year":"2013","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.taap.2025.117247_bb0245","series-title":"Physiology, Acetylcholine. StatPearls. Treasure Island (FL) Ineligible Companies. Disclosure: Bruno Bordoni Declares no Relevant Financial Relationships with Ineligible Companies.: StatPearls Publishing Copyright \u00a9 2024","author":"Sam","year":"2024"},{"key":"10.1016\/j.taap.2025.117247_bb0250","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.seizure.2021.06.028","article-title":"Brain concentrations of glutamate and GABA in human epilepsy: a review","volume":"91","author":"Sarlo","year":"2021","journal-title":"Seizure"},{"key":"10.1016\/j.taap.2025.117247_bb0255","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1600-079X.2007.00436.x","article-title":"Melatonin as a potential antihypertensive treatment","volume":"42","author":"Simko","year":"2007","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.taap.2025.117247_bb0260","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-079X.2009.00697.x","article-title":"Potential roles of melatonin and chronotherapy among the new trends in hypertension treatment","volume":"47","author":"Simko","year":"2009","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.taap.2025.117247_bb0265","first-page":"12","article-title":"Pharmacometabolic effects of Pteryxin and valproate on Pentylenetetrazole-induced seizures in zebrafish reveal Vagus nerve stimulation","author":"Skiba","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.taap.2025.117247_bb0270","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1002\/cne.24235","article-title":"Reorganization of the septohippocampal cholinergic fiber system in experimental epilepsy","volume":"525","author":"Soares","year":"2017","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.taap.2025.117247_bb0275","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/jpi.12199","article-title":"Systemic combined melatonin-mitochondria treatment improves acute respiratory distress syndrome in the rat","volume":"58","author":"Sun","year":"2015","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.taap.2025.117247_bb0280","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0140-6736(18)32596-0","article-title":"Epilepsy in adults","volume":"393","author":"Thijs","year":"2019","journal-title":"Lancet"},{"issue":"Suppl. 6","key":"10.1016\/j.taap.2025.117247_bb0285","first-page":"97","article-title":"Melatonin and serotonin effects on gastrointestinal motility","volume":"58","author":"Thor","year":"2007","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.taap.2025.117247_bb0290","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/0091-3057(75)90133-1","article-title":"Effects of phenylalanine and 5-hydroxytryptophan on seizure severity in mice","volume":"3","author":"Truscott","year":"1975","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.taap.2025.117247_bb0295","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3897\/folmed.63.e58637","article-title":"Melatonin and epilepsy","volume":"63","author":"Vasileva","year":"2021","journal-title":"Folia Med (Plovdiv)."},{"key":"10.1016\/j.taap.2025.117247_bb0300","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s13318-018-0512-8","article-title":"Determination of the pharmacokinetics and tissue distribution of methyl 3,4-Dihydroxybenzoate (MDHB) in mice using liquid chromatography-tandem mass spectrometry","volume":"44","author":"Wang","year":"2019","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.taap.2025.117247_bb0305","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s40263-019-00634-2","article-title":"Objective derivation of the morphology and staging of visual field loss associated with long-term Vigabatrin therapy","volume":"33","author":"Wild","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.taap.2025.117247_bb0310","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.freeradbiomed.2022.09.001","article-title":"Quercetin alleviates kainic acid-induced seizure by inhibiting the Nrf2-mediated ferroptosis pathway","volume":"191","author":"Xie","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2025.117247_bb0315","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12473","article-title":"Melatonin attenuated retinal neovascularization and neuroglial dysfunction by inhibition of HIF-1\u03b1-VEGF pathway in oxygen-induced retinopathy mice","volume":"64","author":"Xu","year":"2018","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.taap.2025.117247_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2024.148991","article-title":"Differential toxic and antiepileptic features of Vigabatrin raceme and its enantiomers","volume":"1838","author":"Xu","year":"2024","journal-title":"Brain Res."},{"key":"10.1016\/j.taap.2025.117247_bb0325","article-title":"Pharmacological characterization of an antisense knockdown zebrafish model of Dravet syndrome: inhibition of epileptic seizures by the serotonin agonist fenfluramine","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2025.117247_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsps.2023.101934","article-title":"Pharmacokinetics and tissue distribution of vigabatrin enantiomers in rats","volume":"32","author":"Zheng","year":"2024","journal-title":"Saudi Pharm J."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25000237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X25000237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T11:13:53Z","timestamp":1740482033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X25000237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":66,"alternative-id":["S0041008X25000237"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2025.117247","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of melatonin on the pharmacokinetics and amino acid metabolism profile of vigabatrin in rats","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2025.117247","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117247"}}